TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING
Clinical trials for TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING explained in plain language.
Never miss a new study
Get alerted when new TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING trials appear
Sign up with your email to follow new studies for TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for High-Risk breast cancer: immunotherapy after standard care
Disease control Not yet recruitingThis phase 3 trial tests whether adding the immunotherapy drug pembrolizumab to standard post-surgery treatment can help prevent breast cancer from coming back in people with early-stage triple-negative breast cancer who still have cancer after initial chemo and immunotherapy. Ab…
Matched conditions: TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING
Phase: PHASE3 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 26, 2026 09:51 UTC
-
Gut check: can your diet boost breast cancer treatment?
Knowledge-focused Not yet recruitingThis study looks at how the bacteria in your gut might influence how well treatment works for early-stage triple-negative breast cancer. Researchers will collect stool, blood, and tumor samples from 300 women before, during, and after chemotherapy and immunotherapy. The goal is t…
Matched conditions: TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING
Sponsor: Barts & The London NHS Trust • Aim: Knowledge-focused
Last updated May 26, 2026 10:05 UTC